Cambinol
-
Catalog number1653-10
-
PricePlease ask
-
Size10 mg
-
-
Alternative_name5-[(2-hydroxy-5,8-dihydronaphthalen-1-yl)methyl]-6-phenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; NSC-112546
-
DescriptionAn inhibitor of NAD-dependent deacetylase activity of human SIRT1 (IC₅₀ = 56 µM) and SIRT2(IC₅₀ = 59 µM). Acts as an antitumor agent. Treatment of BCL6-expressing Burkitt lymphoma cells with Cambinol induces apoptosis accompanied by hyperacetylation of BCL6 and p53.
-
CAS Number14513-15-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₁₆N₂O₂S
-
Molecular Weight360.43
-
Cell PermeableYes
-
Purity≥95% by HPLC
-
SolubilitiesDMSO (10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA SIRT1 inhibitor
-
Storage Condition+4°C
-
Shipping ConditionRT
-
Shelf Life24 months
-
MDL NumberMFCD09057543
-
PubChem CID3246390
-
SMILESC1=CC=C(C=C1)C2=C(C(=O)NC(=S)N2)CC3=C(C=CC4=CC=CC=C43)O
-
InChiInChI=1S/C21H16N2O2S/c24-18-11-10-13-6-4-5-9-15(13)16(18)12-17-19(14-7- 2-1-3-8-14)22-21(26)23-20(17)25/h1-11,24H,12H2,(H2,22,23,25,26)
-
InChi KeyRVNSQVIUFZVNAU-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCambinol
-
Alternative nameCambinol
-